These data suggest that the biphasic response of EPCs in PAD pathogenesis could be associated with changes in MT1-MMP expression [69], although its role as a potential biomarker in PAD needs to be confirmed in larger cohorts. Here, MMP14 is linked to peripheral arterial disease.